Copyright 2014 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
To the Editor In a recently published article1 that used a meta-analysis to estimate costs of health care–associated infections (HCAIs), the conclusion, which was reinforced in the accompanying Editor’s Note,2 suggested that, in light of a newly imposed Centers for Medicare & Medicaid Services policy wherein treatment for such infections will no longer be reimbursed, awareness of the high costs of these infections—estimated to be almost $10 billion per year—would lead hospitals to invest in appropriate improvement programs.
Krupka D, Sandberg W, Weeks W. Will a Policy of Refusing Reimbursement for Health Care–Associated Infections Be a Sufficient Incentive to Drive Improvements?. JAMA Intern Med. 2014;174(5):823. doi:10.1001/jamainternmed.2014.39